Morning Briefing
Summaries of health policy coverage from major news organizations
WHO Executive Board Meeting Addresses Agency's Policy On Counterfeit, Substandard Medications
Intellectual Property Watch reports on how delegates at WHO's executive board meeting used Wednesday to discuss WHO policy on counterfeit and substandard medications. According to the news service, WHO "members
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
